AIMMUNE THERAPEUTICS, INC.: common_shares_outstanding

Value{"unit": "shares", "value": 58730708, "concept": "dei:EntityCommonStockSharesOutstanding"}
Period (as of 2018-10-31)
Statuscurrent
EntityAIMMUNE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-18-028572 · Open the official SEC filing →
Retrieved: 2026-08-19T16:46:43.812497+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001631650/common-shares-outstanding/2018-10-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/24c9f38b-dcfb-433f-bde6-625fd1a3c002

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies